Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.

Sadatsafavi M, Lynd LD, Marra CA, FitzGerald JM.

Thorax. 2014 Apr;69(4):328-34. doi: 10.1136/thoraxjnl-2013-203998. Epub 2013 Nov 26.

PMID:
24281327
2.
3.

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.

PMID:
16235409
4.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003137.

PMID:
17054161
5.

Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.

Blanchette CM, Culler SD, Ershoff D, Gutierrez B.

Clin Ther. 2009 Nov;31(11):2574-83. doi: 10.1016/j.clinthera.2009.11.007.

PMID:
20110003
6.

Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study.

Sadatsafavi M, Lynd L, Marra C, Bedouch P, Fitzgerald M.

J Allergy Clin Immunol. 2013 Jul;132(1):63-9. doi: 10.1016/j.jaci.2013.02.007. Epub 2013 Mar 29.

PMID:
23545274
7.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

8.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2011 May 11;(5):CD003137. doi: 10.1002/14651858.CD003137.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003137.

PMID:
21563136
9.

Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.

Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.

Ann Pharmacother. 2010 Apr;44(4):613-22. doi: 10.1345/aph.1M243. Epub 2010 Mar 16.

PMID:
20233915
10.

Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.

Dal Negro RW, Borderias L, Zhang Q, Fan T, Sazonov V, Guilera M, Taylor SD.

BMC Pulm Med. 2009 Mar 30;9:10. doi: 10.1186/1471-2466-9-10.

11.

Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.

Eltonsy S, Forget A, Beauchesne MF, Blais L.

J Allergy Clin Immunol. 2015 Jan;135(1):123-30. doi: 10.1016/j.jaci.2014.07.051. Epub 2014 Sep 13.

PMID:
25226849
12.

One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.

Sadatsafavi M, Lynd LD, De Vera MA, Zafari Z, FitzGerald JM.

Respir Med. 2015 Mar;109(3):320-8. doi: 10.1016/j.rmed.2014.12.014. Epub 2015 Jan 7.

13.

Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.

Rodrigo GJ, Moral VP, Marcos LG, Castro-Rodriguez JA.

Pulm Pharmacol Ther. 2009 Feb;22(1):9-19. doi: 10.1016/j.pupt.2008.10.008. Epub 2008 Nov 5. Review.

PMID:
19026757
14.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

15.

The use of long-acting β2- agonists as monotherapy in children and adults.

Camp PG, Zhang T, Smith MA, Carleton BC.

J Popul Ther Clin Pharmacol. 2013;20(1):e1-12. Epub 2013 Jan 23.

PMID:
23392793
16.

Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.

Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.

Curr Med Res Opin. 2009 Sep;25(9):2251-8. doi: 10.1185/03007990903155915.

PMID:
19622006
17.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137.

PMID:
15674901
18.

A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma.

Castro-Rodriguez JA, Rodrigo GJ.

Pediatrics. 2012 Sep;130(3):e650-7. doi: 10.1542/peds.2012-0162. Epub 2012 Aug 27. Review.

PMID:
22926172
19.

A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids.

Elkout H, McLay JS, Simpson CR, Helms PJ.

Arch Dis Child. 2010 Oct;95(10):817-21. doi: 10.1136/adc.2009.179069. Epub 2010 Jul 23.

PMID:
20656730
20.

Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.

Gibson PG, Powell H, Ducharme F.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005076. Review.

PMID:
16235393

Supplemental Content

Support Center